PSMA PET/CT Nearly Halves Biopsy Rate in Equivocal Prostate MRI Cases

Among men with equivocal or non-suspicious prostate MRI, PSMA PET/CT reduced the biopsy rate by nearly 50% compared to standard workup, according to a new study.

• The study found that using PSMA PET/CT in this setting may safely avoid an invasive biopsy for a substantial proportion of men.
• See source for details.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.